Comparison of induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil (TPF) followed by radiation vs concurrent chemoradiotherapy with TPF in patients with locally advanced squamous cell carcinoma of the head and neck

Clinical Oncology

Volumn 17, Issue 3, 2005, Pages 148-152

  Katori, Hideaki ^a   Tsukuda, M ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

5 fluorouracil; Chemoradiotherapy; Cisplatin; Concurrent; Docetaxel; Squamous cell carcinoma of the head and neck (SCCHN)

Indexed keywords

CISPLATIN; DOCETAXEL; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ALOPECIA; ANEMIA; ANOREXIA; ARTICLE; BONE MARROW SUPPRESSION; BONE PAIN; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE REGIMEN; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; FEVER; FREQUENCY ANALYSIS; HEAD AND NECK CARCINOMA; HEMATOLOGIC DISEASE; HUMAN; LEUKOPENIA; LIVER DYSFUNCTION; MALE; MUCOSA INFLAMMATION; MYALGIA; NAUSEA; NEPHROTOXICITY; NEUTROPENIA; PRIORITY JOURNAL; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; FEMALE; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; RADIOTHERAPY; SURVIVAL ANALYSIS; TAXOIDS; TREATMENT OUTCOME;

EID: 16344396293     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2004.09.013     Document Type: Article

References (22)

1. S.H. Landis T. Murray S. Bolden et al. Cancer statistics CA Cancer J Clin 49 1999 8-31
2. G.L. Clayman S.M. Lipman G.E. Laramore W. Ki Hong Head and neck neoplasms In: J.F. Holland D.W. Kufe R.E. Pollock et al. eds. Holland-Frei cancer medicine 5th edn 2000 BC Decker Philadelphia, PA 1173-1220
3. The Department of Veterans Affairs Cancer Study Group Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer N Engl J Med 324 1991 1685-1690
4. M. Merlano M. Benasso R. Corvo et al. Five year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in the treatment of unresectable squamous cell carcinoma of the head and neck J Natl Cancer Inst 88 1996 583-589
5. J.L. Lefebre D. Chevalier B. Luboinski et al. Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer Phase III trial J Natl Cancer Inst 88 1996 890-898
6. S. El-Sayed N. Nelson Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region: A meta-analysis of prospective randomized trials J Clin Oncol 14 1996 838-847
7. J.P. Pignon J. Bourhis C. Domenge et al. on behalf of the MACH-NC Collaborative Group Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data Lancet 355 2000 949-955
8. J. Janinis G. Papadakou G. Panagos et al. A phase II study of combined chemotherapy with docetaxel, cisplatin and 5-fluorouracil in patients with advanced squamous cell carcinoma of the head and neck and nasopharyngeal cancer Proc Am Soc Clin Oncol 16 1997 402a
9. A. Colevas C. Norris R. Tishler et al. Phase II trial of docetaxel, cisplatin, fluorouracil, and leucovorin as induction for squamous cell carcinoma of the head and neck J Clin Oncol 17 1999 3503-3511
10. D. Schrijvers C. Van Herpen J. Kerger et al. Phase I-II study with docetaxel (D), cisplatin (C) and 5-fluorouracil (5-FU) in patients (pts) with locally advanced inoperable squamous cell carcinoma of the head and neck (SCCHN) Eur J Cancer 35 suppl 4 1999 164a
11. M. Koukourakis J. Bizakis C. Skoulakis et al. Combined irinotecan, docetaxel and conventionally fractionated radiotherapy in locally advanced head and neck cancer. A phase I dose escalation study Anticancer Res 19 1999 2305-2309
12. M. Tsukuda Y. Mikami Y. Tanigaki et al. Modified TPF was manageable and showed favorable response in patients with locally advanced HNSCC [abstract 2041] Proc Am Soc Clin Oncol 22 2003 57
13. H. Katori M. Tsukuda I. Mochimatu et al. Phase I Trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN) Br J Cancer 90 2004 348-352
14. World Health Organization WHO Handbook for reporting results of cancer treatment WHO offset publication No. 48 1979 World Health Organization Geneva, Switzerland
15. D.R. Cox Regression models and life tables J R Stat Soc B 34 1972 187-220
16. J. Pignon J. Bourhis C. Domenge et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell cancer: Three meta-analysis of updated individual data Lancet 355 2000 949-955
17. S. Taylor A. Murthy J. Vannetzel et al. Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer J Clin Oncol 12 1994 385-395
18. M. Merlano R. Rosso R. Sertoli et al. Sequential versus alternating chemotherapy and radiotherapy in stage III-IV squamous c carcinoma of the head and neck: A phase III study J Clin Oncol 6 1988 627-632
19. G. Catimel J. Verwij A. Hanauska Docetaxel (taxotere): An active drug for treatment of the treatment of the head and neck Ann Oncol 5 1994 553-557
20. C. Couteau S. Leyvraz D. Oulid-Aissa et al. A Phase II study of docetaxel in squamous cell carcinoma (SCC) of the head and neck [abstract] Proc Am Soc Clin Oncol 15 1996 315
21. A. Mauer G. Masters D. Haraf et al. Phase I study of docetaxel with concomitant thoracic radiation therapy J Clin Oncol 16 1998 159-164
22. S.G. Taylor 4th A.K. Murthy J.M. Vannetzel et al. Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer J Clin Oncol 12 1994 385-395